A new bile acid treatment for non-alcoholic fatty liver disease

被引：5
作者：
Chan, Wah Kheong [1 ]
Wong, Vincent Wai-Sun [2 ,3 ]
机构：
[1] Univ Malaya, Gastroenterol & Hepatol Unit, Kuala Lumpur, Malaysia
[2] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Shatin, Hong Kong, Peoples R China
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2019年 / 4卷 / 10期
关键词：
URSODEOXYCHOLIC ACID; STEATOHEPATITIS;
D O I：
10.1016/S2468-1253(19)30183-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：747 / 749
页数：4
相关论文
共 10 条
  • [1] Nor-ursodeoxycholic acid reverses hepatocyte-specific nemo-dependent steatohepatitis
    Beraza, Naiara
    Ofner-Ziegenfuss, Lisa
    Ehedego, Haksier
    Boekschoten, Mark
    Bischoff, Stephan C.
    Mueller, Michael
    Trauner, Michael
    Trautwein, Christian
    [J]. GUT, 2011, 60 (03) : 387 - 396
  • [2] High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
    Leuschner, Ulrich F. H.
    Lindenthal, Birgit
    Herrmann, Guenter
    Arnold, Joachim C.
    Roessle, Martin
    Cordes, Hans-Joerg
    Zeuzem, Stefan
    Hein, Jasper
    Berg, Thomas
    [J]. HEPATOLOGY, 2010, 52 (02) : 472 - 479
  • [3] Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial
    Lindor, KD
    Kowdley, KV
    Heathcote, EJ
    Harrison, ME
    Jorgensen, R
    Angulo, P
    Lymp, JF
    Burgart, L
    Colin, P
    [J]. HEPATOLOGY, 2004, 39 (03) : 770 - 778
  • [4] Pockros PJ, 2018, HEPATOLOGY, V68, p951A
  • [5] Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
    Targher, Giovanni
    Day, Christopher P.
    Bonora, Enzo
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (14) : 1341 - 1350
  • [6] Norursodeoxycholic acid versus placebo in the treatment of non-alcoholic fatty liver disease: a double-blind, randomised, placebo-controlled, phase 2 dose-finding trial
    Traussnigg, Stefan
    Schattenberg, Jorn M.
    Demir, Munevver
    Wiegand, Johannes
    Geier, Andreas
    Teuber, Gerfinde
    Hofmann, Wolf Peter
    Kremer, Andreas E.
    Spreda, Frank
    Kluwe, Johannes
    Petersen, Jorg
    Boettler, Tobias
    Rainer, Florian
    Halilbasic, Emina
    Greinwald, Roland
    Prols, Markus
    Manns, Michael P.
    Fickert, Peter
    Trauner, Michael
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2019, 4 (10): : 781 - 793
  • [7] Metabolic and histological features of non-alcoholic fatty liver disease patients with different serum alanine aminotransferase levels
    Wong, V. W-S.
    Wong, G. L. -H.
    Tsang, S. W-C.
    Hui, A. Y.
    Chan, A. W-H.
    Choi, P. C-L.
    Chim, A. M-L.
    Chu, S.
    Chan, F. K. -L.
    Sung, J. J-Y.
    Chan, H. L. -Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (04) : 387 - 396
  • [8] Noninvasive biomarkers in NAFLD and NASH - current progress and future promise
    Wong, Vincent Wai-Sun
    Adams, Leon A.
    de Ledinghen, Victor
    Wong, Grace Lai-Hung
    Sookoian, Silvia
    [J]. NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2018, 15 (08) : 461 - 478
  • [9] YOUNOSSI Z, 2019, J HEPATOL S, V70, pE
  • [10] Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Younossi, Zobair
    Tacke, Frank
    Arrese, Marco
    Sharma, Barjesh Chander
    Mostafa, Ibrahim
    Bugianesi, Elisabetta
    Wong, Vincent Wai-Sun
    Yilmaz, Yusuf
    George, Jacob
    Fan, Jiangao
    Vos, Miriam B.
    [J]. HEPATOLOGY, 2019, 69 (06) : 2672 - 2682
1